NW
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy | Antiviral research | 2024 | 47 | 28 | |||
Regulation of SARS-CoV-2 and Influenza A virus entry by intrinsic host cell surface proteins | 2024 | 29 | 0 | ||||
Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3 | Journal of virology | 2024 | 138 | 7 | |||
Influenza A virus exploits transferrin receptor recycling to enter host cells | Proceedings of the National Academy of Sciences of the United States of America | 2023 | 219 | 86 | |||
Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells | Microbiology spectrum | 2023 | 95 | 26 | |||
Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groups | Journal of virology | 2022 | 161 | 195 | |||
Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages | EMBO Reports | 2020 | 295 | 0 |